Report cover image

Europe Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Oct 31, 2023
Length 141 Pages
SKU # KBV18339085

Description

Europe Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Country and Growth Forecast, 2023 - 2030


The Europe Implantable Cardioverter Defibrillator Market would witness market growth of 5.7% CAGR during the forecast period (2023-2030).

The implantable cardioverter defibrillator (ICD) is an electronic medical device that monitors and controls cardiac rhythms in patients at risk for life-threatening arrhythmias, such as ventricular tachycardia and ventricular fibrillation. Technological advancements, an escalating incidence of sudden cardiac arrest, a growing public awareness, and supportive government and healthcare policies contribute to the market's expansion. With the increasing prevalence of cardiovascular diseases, it is anticipated that the demand for advanced cardiac care solutions, such as ICDs, will increase, creating opportunities for expansion and innovation in the healthcare industry.

The rising frequency of cardiac diseases and related risk factors, which make sudden cardiac arrest (SCA) deaths a substantial cause of mortality, are predicted to increase the demand for cardiac resynchronization therapy devices (CRT-Ds). A further factor in the need for CRT-Ds is heart failure, a leading cause of death. The increasing incidence of SCA has increased the demand for defibrillators, as survival rates remain low, particularly for out-of-hospital cases. ICDs are essential for patients with abnormal heart rhythms, with a greater prevalence among older individuals with coronary artery disease (CAD).

As per the European Cardiovascular Disease Statistics 2017, cardiovascular disease (CVD) causes over 1.8 million fatalities in the European Union and over 3.9 million deaths in Europe each year. In Europe and the EU, CVD is the primary cause of mortality in 45% and 37% of cases, respectively. CVDs are the leading cause of death in Europe. These diseases encompass various conditions, including coronary artery disease, heart failure, arrhythmias, and others. The prevalence of CVDs varies across European countries but is generally high. Several risk factors contribute to most European CVDs, including smoking, unhealthy dietary habits, physical inactivity, obesity, and excessive alcohol consumption. These risk factors are often modifiable through lifestyle changes and interventions.

The Germany market dominated the Europe Implantable Cardioverter Defibrillator Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $371 million by 2030. The UK market is experiencing a CAGR of 4.8% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 6.5% during (2023 - 2030).

Based on Type, the market is segmented into Biventricular Devices, Dual Chamber ICDs and Single Chamber ICDs. Based on Product Type, the market is segmented into Transvenous and Subcutaneous. Based on NYHA Class, the market is segmented into NYHA Class II and NYHA Class III. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), LivaNova PLC, Koninklijke Philips N.V. and Getinge AB.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Biventricular Devices
  • Dual Chamber ICDs
  • Single Chamber ICDs
By Product Type
  • Transvenous
  • Subcutaneous
By NYHA Class
  • NYHA Class II
  • NYHA Class III
By End-use
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Abbott Laboratories
  • Medtronic PLC
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • ZOLL Medical Corporation (Asahi Kasei Corporation)
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • Getinge AB
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

141 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Implantable Cardioverter Defibrillator Market, by Type
1.4.2 Europe Implantable Cardioverter Defibrillator Market, by Product Type
1.4.3 Europe Implantable Cardioverter Defibrillator Market, by NYHA Class
1.4.4 Europe Implantable Cardioverter Defibrillator Market, by End-use
1.4.5 Europe Implantable Cardioverter Defibrillator Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Implantable Cardioverter Defibrillator Market
Chapter 5. Europe Implantable Cardioverter Defibrillator Market, By Type
5.1 Europe Biventricular Devices Market, By Country
5.2 Europe Dual Chamber ICDs Market, By Country
5.3 Europe Single Chamber ICDs Market, By Country
Chapter 6. Europe Implantable Cardioverter Defibrillator Market, By Product Type
6.1 Europe Transvenous Market, By Country
6.2 Europe Subcutaneous Market, By Country
Chapter 7. Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
7.1 Europe NYHA Class II Market, By Country
7.2 Europe NYHA Class III Market, By Country
Chapter 8. Europe Implantable Cardioverter Defibrillator Market, By End-use
8.1 Europe Hospitals Market, By Country
8.2 Europe Ambulatory Surgical Centers Market, By Country
8.3 Europe Others Market, By Country
Chapter 9. Europe Implantable Cardioverter Defibrillator Market, By Country
9.1 Germany Implantable Cardioverter Defibrillator Market
9.1.1 Germany Implantable Cardioverter Defibrillator Market, By Type
9.1.2 Germany Implantable Cardioverter Defibrillator Market, By Product Type
9.1.3 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class
9.1.4 Germany Implantable Cardioverter Defibrillator Market, By End-use
9.2 UK Implantable Cardioverter Defibrillator Market
9.2.1 UK Implantable Cardioverter Defibrillator Market, By Type
9.2.2 UK Implantable Cardioverter Defibrillator Market, By Product Type
9.2.3 UK Implantable Cardioverter Defibrillator Market, By NYHA Class
9.2.4 UK Implantable Cardioverter Defibrillator Market, By End-use
9.3 France Implantable Cardioverter Defibrillator Market
9.3.1 France Implantable Cardioverter Defibrillator Market, By Type
9.3.2 France Implantable Cardioverter Defibrillator Market, By Product Type
9.3.3 France Implantable Cardioverter Defibrillator Market, By NYHA Class
9.3.4 France Implantable Cardioverter Defibrillator Market, By End-use
9.4 Russia Implantable Cardioverter Defibrillator Market
9.4.1 Russia Implantable Cardioverter Defibrillator Market, By Type
9.4.2 Russia Implantable Cardioverter Defibrillator Market, By Product Type
9.4.3 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class
9.4.4 Russia Implantable Cardioverter Defibrillator Market, By End-use
9.5 Spain Implantable Cardioverter Defibrillator Market
9.5.1 Spain Implantable Cardioverter Defibrillator Market, By Type
9.5.2 Spain Implantable Cardioverter Defibrillator Market, By Product Type
9.5.3 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class
9.5.4 Spain Implantable Cardioverter Defibrillator Market, By End-use
9.6 Italy Implantable Cardioverter Defibrillator Market
9.6.1 Italy Implantable Cardioverter Defibrillator Market, By Type
9.6.2 Italy Implantable Cardioverter Defibrillator Market, By Product Type
9.6.3 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class
9.6.4 Italy Implantable Cardioverter Defibrillator Market, By End-use
9.7 Rest of Europe Implantable Cardioverter Defibrillator Market
9.7.1 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type
9.7.2 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type
9.7.3 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
9.7.4 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use
Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Trails and Approvals:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Biotronik SE & Co. KG
10.3.1 Company Overview
10.3.2 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 SWOT Analysis
10.5 MicroPort Scientific Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.6 SWOT Analysis
10.7 ZOLL Medical Corporation (Asahi Kasei Corporation)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 LivaNova PLC
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 Koninklijke Philips N.V.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Getinge AB
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us